Robert M. Borzilleri,Peiyung Liu,Andrew J. Tebben,Upender Velaparthi,Hasibur Rahaman,Gopikishan Tonukunuru,Jayakumar Sankara Warrier
申请号：
US16316714
公开号：
US20190292179A1
申请日:
2017.07.19
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
